Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Next Stem Cell President Should be Hands-on, Scientific Administrator; Consumer Advocates Urge

Published: Monday, February 05, 2007
Last Updated: Monday, February 05, 2007
Bookmark and Share
Focusing on big names could result in hiring a figurehead rather than an executive committed to making the stem cell institute work in the public's best interest.

California's stem cell oversight committee should focus on finding a competent, hands-on administrator to replace retiring Dr. Zach Hall as president of the California Institute for Regenerative Medicine (CIRM), said the Foundation for Taxpayer and Consumer Rights (FTCR).

"Members of the search committee should avoid the temptation of seeking a 'big-name' scientist known for his or her discoveries," said John M. Simpson, FTCR Stem Cell Project Director. "The emphasis must be on the individual's skills in scientific management and administration."

Focusing on big names could result in hiring a figurehead rather than an executive committed to making the stem cell institute work in the public's best interest, FTCR said.

The presidential search committee meets at 3 p.m. Wednesday, Jan. 31, in San Francisco. In a letter to Robert Klein committee chairman, Simpson said that Dr. Hall had exemplified the qualities necessary for the position during his two years in the job.

"The next president must be an extremely competent hands-on scientific administrator, who can set up and maintain transparent and accountable management systems," Simpson wrote. "He or she must be able to interact with the public, state officials, legislators and the media in a transparent, honest and accountable fashion."

In the past there have been suggestions that the president of the California Institute for Regenerative Medicine (CIRM) might continue to maintain a research laboratory as part of the president's role. This should not be allowed, FTCR said.

"The presidency of CIRM is more than a full-time job, "said Simpson.”A person trying to manage CIRM's activities and conduct meaningful research simultaneously would do justice to neither activity."

Finally, while there are a number of individuals on the ICOC itself who have performed admirably in their positions as scientific administrators, FTCR said CIRM's interests would be best served if the search does not consider them and looks beyond the oversight committee.

Dr. Hall announced at the stem cell oversight committee's December meeting that he wished to retire within six months.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

California Stem Cell Agency Exaggerated its Role in Funding Key Research
California's stem cell agency overstated and hyped the importance of its funding in enabling clinical trials for a drug to treat a severe blood disorder.
Thursday, April 17, 2008
CIRM to Announce new Faculty Awards to Fund Next Generation of Stem Cell Scientists
CIRM will announce up to $85 million in New Faculty Awards at the December 12 meeting of its governing body, the Independent Citizens Oversight Committee.
Tuesday, December 11, 2007
Stem Cell Research Headed by $45 Million in California
The 29-member Independent Citizens Oversight approves 72 grants to researchers at 20 academic and non-profit research centers throughout the state.
Friday, February 23, 2007
Scientific News
The Mending Tissue - Cellular Instructions for Tissue Repair
NUS-led collaborative study identifies universal mechanism that explains how tissue shape regulates physiological processes such as wound healing and embryo development.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
iPS Cells Discover Drug Target for Muscle Disease
Researchers have designed a model that reprograms fibroblasts to the early stages of their differentiation into intact muscle cells in a step towards a therapeutic for Duchenne muscular dystrophy.
Engineered Hot Fat Implants Reduce Weight Gain
Scientists at UC Berkeley have developed a novel way to engineer the growth and expansion of energy-burning “good” fat, and then found that this fat helped reduce weight gain and lower blood glucose levels in mice.
Transplanted Stem Cells Can Benefit Retinal Disease Sufferers
Tests on animal models show that MSCs secrete growth factors that suppress causes of diabetic retinopathy and macular degeneration.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
Early Detection of Lung Cancer
The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung cancer cases from the UKCTOCS biobank, with the aim of discovering new blood-based biomarkers for earlier detection of the disease.
Researchers Identify Drug Candidate for Skin, Hair Regeneration
Formerly undiscovered role of protein may lead to the development of new medications that stimulate hair and skin regeneration in trauma or burn victims.
Basis for New Treatment Options for a Fatal Leukemia in Children Revealed
Detailed molecular analyses allow new insights into the function of tumour cells and options for new treatments.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!